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= Abstract =
Purpose: Staphylococcal scalded skin syndrome (SSSS) is a relatively uncommon superficial blistering skin disease that is 
due to Staphylococcus aureus. We had experienced a regional outbreak of SSSS over 3 years in healthy children. 
Methods: We retrospectively reviewed the medical records of those patients diagnosed as SSSS. Most of neonatal cases 
were  nosocomial  infections  and  excluded from  the  analysis.  The clinical  features, laboratory  findings,  the  isolation  and 
antibiotic resistance of S. aureus, the antibiotic management and other supportive treatments were analyzed.
Results :Fifty-five patients with SSSS were admitted to our hospital from October 2001 to September 2004. The median 
age of patients was 3.0 years. Of the 55 patients, 9 were the generalized type, 13 were the intermediate type and 33 
were the scarletiniform rash. All the patients were living in neighborhood of the Jinju area. S. aureus were isolated from 
9 of the patients and all of the isolated S. aureus were methicillin resistant. All the patients except two were treated with 
intravenous flocloxacillin or nafcillin and/or cefotaxime. All the patients recovered during the follow-up period of 2 to 3 
weeks.
Conclusion :We experienced a regional outbreak of SSSS in previous healthy children. Further study for finding the carriers
of S. aureus caused SSSS and preventing the spread of this disease is needed. Additionally, guidelines for treating SSSS 
due to methicillin resistant S. aureus should be established. (Korean J Pediatr 2010;53:48-55)
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Introduction
Staphylococcal scalded skin syndrome (SSSS) is a rela-
tively uncommon superficial blistering skin disease that is 
caused by  the  exfoliative  toxins  (ET)  of  Staphylococcus 
aureus (S. aureus)
1). Its clinical manifestations are varied 
and they include the generalized, localized (bullous impeti-
go),  abortive  (scarletiniform  rash)  and  the  intermediate 
forms
2, 3). The scarletiniform rash is also called staphylo-
coccal scarlet fever, and this is generally considered to be 
a milder form that is characterized by fever and a gene-
ralized tender erythema without exfoliation or the formation 
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of bullae. 
The diagnosis of SSSS is mainly based on clinical ap-
pearance, and it is confirmed by the isolation of S. aureus 
or the exfoliative toxin (ET) and/or the histopathological 
findings. However, the typical SSSS presents for several 
days, and the generalized SSSS is a rare condition that us-
ually occurs in neonates. Thus, a structured management 
approach  to  this  disease  that  involves  a  high  index  of 
suspicion is recommended
4).
SSSS cases caused by methicillin resistant staphylococ-
cus aureus (MRSA) have recently been reported both in 
our country and worldwide
5). The choice of antibiotics for 
a community acquired MRSA skin infection has been con-
troversial
6).
From late 2001, skin lesions presumed by bacterial in-
fection developed persistently. Firstly, we diagnosed scar-
letiniform rash due to erythema, bullae, positive Nikolsky 
sign and itching. We investigated the prevalence of these 
skin lesions, and there was a mixture of generalized SSSS, Regional outbreak of SSSS in healthy children
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Fig. 1. Generalized  Staphylococcal  scalded  skin  syndrome  (SSSS) 
in  a  previously  healthy  child  of  27-month-old.  The  photograph 
(A  and  B)  shows  the characteristic  erythematous  superficial  exfo-
liation  with  a positive  Nikolsky sign.
Fig. 2. Intermediate  type  of  Staphylococcal 
scalded  skin  syndrome  (SSSS)  in  an  infant. 
The  A,  B  and C show tender  erythema and
several bullae with a positive Nikolsky  sign.
scarletiniform rash, and bullous impetigo. 
Many  outbreaks  of  SSSS  have  been  reported
7, 8, 10, 11). 
Small  outbreaks  in  children  or  a  few  familial  outbreak 
cases
13) also have been reported. However, any continuing 
outbreak of SSSS in children over a few years had been 
rarely observed.
In this study, we considered clinical symptoms, antimi-
crobial susceptibility and regional outbreak of SSSS over a 
few years. 
Materials and methods
From Oct 2001 through Sep 2004, 72 patients from the 
Department of Pediatrics, Gyeongsang National University 
Hospital (GNUH) who were admitted and diagnosed with 
SSSS were identified. Hospital records and laboratory re-
cords were  reviewed  to  obtain  information,  including the 
patients’ ages, gender, site of initiation, the clinical features 
of SSSS, the laboratory findings, the culture and antibiotic 
resistance of S. aureus, and we also report on the proper 
antibiotic management and the other supportive treatments.
In this study, the localized SSSS cases (bullous impetigo) 
were excluded due to the fact that most of these patients 
were not admitted and they were managed with oral anti-
biotics. 
The  patients  were  classified  according  to  three  skin 
manifestation: the generalized type (group 1), defined as a 
case  where  there  was  tender  erythema  and  large  bullae 
involving over 30% of whole body with a positive Nikolsky 
sign; the intermediate type (group  2),  defined  as a case 
where there was tender erythroderma and several vesicles 
or pustules with a positive Nikolsky sign; and the abortive 
type  (scarletiniform  rash,  group  3),  defined  as  a  case 
where there was tender erythema on the whole body with HJ  Do,  ES  Park,  JY  Lim,  et  al.
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Fig. 3. Scarletiniform  rash  in  children.  The  case  was  tender  erythema  on  the  whole  body 
with  a  negative  Nikolsky  sign,  and  the  erythema  (A,  B  and  C)  is  followed  by  the  thick 
flakes over the next week  (D).
Fig. 4. Annual  incidence  of  Staphylococcal  scalded  skin  syndrome  (SSSS).  The  annual  inci-
dence  and  number  of  case  diagnosed  in  Staphylococcal  scalded  skin  syndrome  (SSSS)  was 
abruptly  increased  during  2001  to 2004.
a negative Nikolsky sign (Fig. 1-3)
3).
Results
1. Prevalence of SSSS
From Oct 2001 to Sep 2004, a total of 9,891 were admitted 
in Department of Pediatrics, GNUH, and the patients who 
were diagnosed in SSSS were 0.56% (55/9,891). Annual 
prevalence  (number  of  1,000  admitted  patients)  was 
abruptly increased during Oct 2001 to Sep 2004, compared 
with  previous  annual  prevalence  (Fig.  4).  Seventy-two 
patients with SSSS were admitted to our hospital from Oct 
2001 to Sep 2004. Seventeen of 72 patients were neonates Regional outbreak of SSSS in healthy children
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Table  1.  Age  Distribution  and  Clinical  Subtypes  of  Children 
Diagnosed  as Staphylococcal  Scalded  Skin  Syndrome
Age (yr) Group 1 Group 2 Group 3 Total
<1 
1-2
2-3
3-4
4-5
>5
Total
4
1
0
3
1
0
9
  1
  1
  4
  5
  1
  1
13
  1
  5
  8
  8
  4
  7
33
 6
 7
12
16
 6
 8
55
Group  1  : The  generalized  type
Group  2  : The  intermediate type
Group  3  : The  abortive type (scarletiniform rash)
Fig. 5. Monthly incidence of Staphylococcal scalded skin syndrome (SSSS). This figure showed 
that  high  prevalence  in Sep  and Oct.
(<28 days of age) and 11 of the seventeen cases were born 
in same hospital, and a nursery-associated outbreak was 
suspected. The onset of the disease varied from 5 to 25 days 
after  their  discharge  from  that  hospital,  but  these  were 
considered as nosocomial infection, so all cases of neonates 
were excluded in this study. 
The study group was composed of 30 boys and 25 girls 
(the boy:girl ratio was equal to 1.2:1). The median age of 
the patients was 3.0 years (range: 1 month to 8 years 8 
months) (Table 1). Of the 55 patients, 9 were the genera-
lized type, 13 were the intermediate type and 33 were the 
abortive type. The abortive type was 60% of all cases. The 
generalized type was displayed more in infants than in chil-
dren 1 year old and over. 
2. Clinical symptoms 
Most patients had been transferred to our hospital after 
initial management at the local clinic was done under the 
clinical  impression  of  SSSS,  erythema  multiforme,  skin 
rash, toxic dermatitis, impetigo, atopic dermatitis, urticaria, 
food poisoning, drug rash or scarlet fever. 
Most of our patients initially developed itching, a febrile 
sensation and irritability, and this was followed by a gene-
ralized, tender erythematous rash, which generally begins 
on the head and neck. The initial lesion looked like impetigo 
around the eyes, nose and lips. The rash spread to the rest 
of the body from the head to the lower extremities within 
a week. 
For the patients with the scarletiniform rash, the ery-
throderma  with  sandpaper-like  texture  was  followed  by 
thick flakes developing  within  a few days and the entire 
skin desquamated over the next 2 or 3 weeks. 
Twelve (21%) of the total patients had fever (body tem-
perature ≥38℃) that subsided within 2 days, but 43 pa-
tients had a febrile sensation without fever. 
There were variable coexisting diseases: rhinitis, acute 
pharyngitis,  conjunctivitis,  acute  otitis  media,  gastritis, 
pneumonia and sepsis.
For  one  case  who  was  one-month-old  girl,  she  was 
twice admitted  in  diagnosis  of generalized SSSS.  In  first 
admission, she was transferred to our hospital under im-
pression of collodian baby, and managed with intravenous 
flocloaxcillin for 7 days. The blood culture was positive of 
S. aureus. In fifth day after discharge, she was readmitted 
as same symptom and managed with vancomycin for 7 days.HJ  Do,  ES  Park,  JY  Lim,  et  al.
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Table  2.  The  Results  of  Antibiotic  Sensitivity  Test  of  Staphylo-
coccus  aureus  isolated  from  Patients  diagnosed  as  Staphylococ-
cal  Scalded  Skin  Syndrome
Antibiotics MIC (µg/mL) Sensitivity
Cephalothin
Ciprofloxacin
Clindamycin
Erythromycin
Gentamicin
Nitrofurantoin
Oxacillin
Penicillin-G
Rifampin
Teicoplanin
Tetracylcine
Trimthoprim/Sulfamethoxazole
Vancomycin
≥32
≤0.5
≥8
≥8
≥16
≤32
≥8
≥16
≤1
≤4
≤1
≤10
2
R
S
R
R
R
S
R
R
S
S
S
S
S
Abbreviation : R, resistant;  S, sensitive;  MIC,  minimal  inhibitory 
concentration
3. Prevalence and regional distribution
The  annual  prevalence  was  4  cases  in  2001  (Oct  to 
Nov), 17 cases in 2002, 27 cases in 2003 and 7 cases in 
2004 (Jan to Sep), respectively. The monthly prevalence 
was 4 cases in Jan, 4 cases in Feb. 0 case in Mar, 3 cases 
in Apr, 6 cases in May, 5 cases in Jun, 2 cases in Jul, 1 
case in Aug, 11 cases in Sep, 13 cases in Oct, 3 cases in 
Nov, and 3 cases in Dec (Fig. 5). 
All the patients were living in neighborhood of the Jinju 
area:  Jinju  31,  Sacheon  6,  Tongyeong  6,  Sancheong  1, 
Geoje 3, Goseong 2, Masan 2 and Hadong 4. 
4. Laboratory findings
The  WBC  count  was  slightly  elevated  (mean:  10,432/ 
mm
3)  with  little  or  no  shift  in  the  differential  count.  No 
differences among types of SSSS were present. The levels 
of  C-reactive  protein  were  not  increased  except  one 
patient (23.8 mg/L). The results of the liver function tests, 
electrolytes and serum creatinine were within the normal 
limits at the time of admission. 
In 9 of the total patients, S. aureus was isolated from 
culturing the throat or the wound site. All of the S. aureus 
in these patients was resistant to methicillin. The MRSA 
was  susceptible  to  ciprofloxacin,  nitrofurantoin,  rifampin, 
tetracycline, vancomycin and trimethoprim/sulfamethoxazole. 
Compared  with  the  nosocomial  MRSA  isolated  from  our 
hospital, this MRSA was sensitive to ciprofloxacin, tetra-
cycline and trimethoprim/sulfamethoxazole (Table 2).
For one patient who was diagnosed with sepsis, MRSA 
that had identical antibiotic susceptibility results was iso-
lated from both the blood culture and culture of the perior-
bital pyoderma. 
5. Response to treatment
All  the  patients  except  two  cases  were  treated  with 
intravenous flocloxacillin or nafcillin and/ or cefotaxime (7 
days). In one patient with S. aureus sepsis, the fever and 
formation of bullae persisted for 7 days and so the anti-
biotics were changed to vancomycin. In the other patient 
who  readmitted  after  discharge,  she  was  treated  with 
vancomycin.  Topical  antibiotics  [Bactroban
Ⓡ  (Mupirocin), 
Hanall Co., Seoul, Korea] were applied on the pyoerythema, 
especially on the perioral area or around the nose. Any eye 
discharge  and  conjunctival  injection  were  managed  with 
erythromycin  eye  ointment  (Ecolicn
Ⓡ,
  Tae  Joon  Pharm, 
Seoul,  Korea).  Burrow’s  solution  and  40%  zinc  oxide 
ointment were used for the tender erytheroderma. In most 
of the patients, their fever subsided within 2 days. Within 
5 to 7 days, the erythema begins to resolve, and this was 
followed by desquamation from the head, neck and trunk to 
the  lower  extremities.  The  pyoderma  and  formation  of 
bullae improved within 3 to 5 days. 
There were no complications or deaths, and the progno-
sis was good. At the 2 or 3 week follow up, all the patients 
had recovered without sequelae.  
Discussion
We report here on an epidemic of staphylococcal scalded 
skin syndrome in healthy children. Previously there were 
no endemic or epidemic outbreaks of SSSS in Jinju area.
The rate of scarletiniform rash was 60.0% (33/55). The 
diagnosis of the first patient was difficult due to the fact 
that there was no associated fever, and scarletiniform rash 
is a rare form of SSSS. Scarletiniform rash, also called sta-
phylococcal scarlet fever, or the abortive form of SSSS has 
generally considered as the milder forms of this disease. 
Patients usually develop a generalized tender erythroderma 
with a roughened, sandpaper-like texture, and this is as-
sociated with fever, but in our patients, there was no as-
sociated fever. Unlike the generalized SSSS, bullae did not 
develop. The scarletiniform rash was very difficult to dif-
ferentiate  from  other  causes  of  infectious  erythroderma 
such  as  toxic  shock  syndrome  (TSS)  and  streptococcal Regional outbreak of SSSS in healthy children
- 53 -
scarlet fever
3, 9).
Most of the SSSS outbreak developed among the new-
born who were  cared  for  by an  asymptomatic  carrier  of 
ET-producing S. aureus with generalized SSSS. Curren
10) 
et  al.  reported  on  an  outbreak  of  neonatal  SSSS,  and 
35.3% of the cases had generalized exfoliative dermatitis, 
and 11.8% of the cases had staphylococcal scarlet fever. 
In our study, the cases of generalized SSSS were 4 of 6 
(66.7%) infants who under 1 year old, and 5 of 49 (10.2%) 
in children aged 1 year and older. The number of scarle-
tiniform rash was increased with age. In 1976, a nursery 
outbreak of scarletiniform rash caused by phage group I S. 
aureus was reported
11). Yet in our study, we did not collect 
the isolated bacteria and we didn’t evaluate the exfoliative 
toxin or phage group.
The diagnosis of SSSS is usually based mainly on the 
clinical manifestations, and the diagnosis is supported by 
the presence of S. aureus in the nasal, conjunctival, pha-
ryngeal or wound swabs. Several risk factors of SSSS have 
been  suggested:  poor  renal  clearance  of  the  toxins,  low 
antibody status, immunosuppression with immunosuppres-
sive drugs and malignancy
3). In our study, most of the pa-
tients were preschool-aged children who were relatively 
healthy and they were not immunocompromised, and they 
had no chronic illness or renal disease. We did not examine 
the serum antibody titers against S. aureus. SSSS has re-
cently been described in an individual taking a nonsteroidal 
anti-inflammatory drug (NSAID). These drugs promote S. 
aureus growth and decrease renal clearance of the toxin
9). 
In our study, no patient had been managed with NSAIDs, 
but some of our patients were managed with oral predniso-
lone  under  impression  of  Stevens-Johnson  syndrome  or 
atopic dermatitis before their transfer to our hospital.
In neonates and children, transmission of the exfoliative 
toxin-producing  S.  aureus  appears  to  occur  through 
asymptomatic carriers
8). Community-acquired MRSA infec-
tions have been increasingly reported among athletes and 
in the army. For a college football team, MRSA was spread 
predominantly  during  the  practice  play  with  skin  breaks 
facilitating  infection;  hence,  it  is  important  to  screen  for 
potential  carriers
12). In our  study,  we  did  not prove that 
direct contact  occurred  with  an asymptomatic  carrier,  or 
that the infection was due to previous hospital management. 
Some children denied a direct contact history with patients 
having  skin  lesions.  Ladhani  and  Newson
13)  reported  the 
case of a familial outbreak of SSSS and they suggested the 
importance of identifying and treating the close infectious 
contacts  of  the  patients  with  generalized  SSSS.  In  our 
study, two patients were siblings, and this suggested that 
SSSS  is  contagious  disease.  However,  no  other  family 
including children and adults developed SSSS or impetigo. 
Culture for the other family was not performed in out study. 
Yet in our cases, there were no evidence of disease pro-
pagation to other children in the same room, and most of 
the children played together in the kindergarten. 
During the 3-year study period, 55 cases of SSSS oc-
curred with 9 cases (16.4%) of isolated S. aureus being 
seen on the culture study. The low positive number of cul-
ture  studies  was  perhaps  due  to  that  most  patients  had 
undergone previous antibiotic treatment. Cultural data was 
available for 9 patients, and all were positive for MRSA, 
but further testing for typing the S. aureus could not be 
done. In our country, SSSS due to MRSA has been reported 
and this was managed with intravenous vancomycin
14). We 
used vancomycin in only two cases. The cultural reports 
were usually ready after 3 to 5 days, and the patients who 
had positive culture for MRSA did not have their antibiotics 
changed.
The prompt diagnosis and early treatment for this dis-
ease is important. In treating SSSS, the parenteral antibio-
tics  such as  flocloxacillin  would be  recommended  except 
for localized SSSS, which is managed with a topical agent 
and  oral  antibiotics  that  cover  both  staphylococci  and 
streptococci. Any blisters should be left intact. The eroded 
areas are best covered with white petrolatum-impregnated 
gauze that helps reduce further trauma to the skin. A topi-
cal antibiotic or antiseptic eye ointment is helpful to manage 
the eczema around eyes and lips
1). In our study, we could 
not rule out scarlet fever for the first patient because the 
skin lesions looked like scarlet fever, and the patient was 
without any definitive fever. So, a combination of cefota-
xime and flocloxacillin was used. In our hospital, wet gauze 
with Burrow solution was applied on the blistered skin and 
tender erythema, and 40% zinc oxide ointment made in our 
hospital was used on the scareletiniform rash. Bactroban
Ⓡ 
(mupirocin) ointment was used on the impetigo-like lesions 
around the lips and nose, and on the erosion on the flexural 
areas (neck, axilla and inguinal areas). Severe periorbital 
lesion was managed with eye ointments containing antibiotics 
such as colimycin
Ⓡ (Hanil Parm, Seoul, Korea) or ecolicin
Ⓡ. 
Within 2 to 3 days, the fever usually subsides, the ery-
thema begins to resolve and there is no new bullae forma-HJ  Do,  ES  Park,  JY  Lim,  et  al.
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tion. Because the antibiotics are targeted to the offending 
organism, the exofoliation will continue for another 24 to 
36  hours  after the  start  of  antibiotic administration.  The 
desquamation of the skin generally occurs 3 to 5 days after 
disease  onset,  and  complete  resolution  occurs  in  most 
cases, usually within 2 to 3 weeks with no permanent se-
quelae
1, 3). The facial edema, periorbital eczema, erythema 
and erosion were improved within 3 to 4 days. However, 
the desquamation developed from head to the leg and this 
persisted for 2 to 3 weeks. All 55 patients improved with-
out scarring on the out-patient department follow-up. 
There are several limitations for our study. First, we did 
not do further study to find out the origin of the disease, 
such as taking throat or nasal cultures for S. aureus from 
the adults around the patients. So, we could not explain the 
spread pathway of S. aureus. Second, the isolated MRSA 
was considered as contaminated bacteria in some patients, 
and further study for the phenotyping or the isolation of the 
exfoliative toxin could not done. Third, as all the outbreak 
patients were not included in our study, the accurate num-
ber of SSSS patients remains unknown. 
In summary, we report here on a regional outbreak of 
SSSS  in  previous  healthy  children.  However,  we  did  not 
prove  the  mechanism  of  bacterial  transmission.  If  SSSS 
develops  persistently  in  a  population,  then  further  study 
for finding the MRSA carriers and preventing the spread 
of  this  disease  are  needed.  Additionally,  guidelines  for 
treating SSSS due to MRSA should be established.
한 글 요 약
건강한 소아에서 포도알균화상피부증후군의
지역적 유행 
경상대학교 의과대학 소아과학교실
도현정ㆍ박은실ㆍ임재영ㆍ박찬후ㆍ우향옥ㆍ윤희상ㆍ서지현
목 적: 포도알균화상피부증후군(4S)은 황색 포도알균과 관련
된 표재성 수포가 생기는 거의 드문 피부 질환이다. 저자들은 3
세 이상의 건강한 소아에서 4S의 지역적 유행을 경험하였다.
방 법: 저자들은 4S를 진단받았던 환아들을 대상으로 의학적 
기록을 후향적으로 분석하였다. 신생아들의 경우 외인성 감염이 
대부분이었으므로 이 연구에서 제외되었다. 임상적 특징, 실험 결
과, 황색 포도알균의 항생제 내성과 분리, 항생제 치료와 보존적 
치료법을 분석하였다.
결 과: 2001년 10월부터 2004년 9월까지 본원에 입원하였던 
4S를 진단받은 55명의 소아들을 대상으로 하였다. 환아들의 평
균 나이는 3세였다. 55명의 환아 중에서 9명이 전신형, 13명이 
중간형이었으며  나머지 33명이 성홍열모양 피부발진이 있었다. 
모든 환아들은 진주의 인접한 지역에 살고 있었다. 황색 포도알
균은 9명의 환아에서 분리되었고, 분리된 모든 황색 포도알균은 
methicilline  저항성을  가지고  있었다.  2명을  제외한  환아들은 
flocloxacillin 또는 nafcillin 또는 cefotaxime 정맥 주사로 치료
하였다. 모든 환아들은 2-3주간의 추적 기간 동안 완전히 회복
되었다. 
결 론: 저자들은 이전에 건강했던 소아들에서 4S의 지역적 유
행을 경험하였다. 이 질환의 유행을 막기 위해서 4S를 일으키는 
황색 포도알균의 매개체를 찾기 위한 더 많은 연구가 필요하다. 
부가적으로 methicilline 저항성 황색 포도알균이 많으므로 4S를 
치료하기 위한 지침서가 확립되어야 할 것으로 사료된다. 
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